The next, they're demanding that engineers take over to make up for lost innovation. Be careful that they don't change their minds again.
This is what happened in early December when Pat Gelsinger unexpectedly retired as chief executive and director of Intel. The Pennsylvania-born engineer, who helped pioneer USB ports and Wi-Fi, had been appointed on Jan. 13, 2021, with a mandate to regain lost technological ground from Taiwan Semiconductor Manufacturing Co. and Advanced Micro Devices. The chip maker's shares rose almost 7% on the news.
On the day Gelsinger stepped down, they closed roughly flat. Investors weren't heartbroken to see him go.
Kelly Ortberg needs to take note: Earlier this year, he took charge of Boeing, the other big fallen angel of American manufacturing.
To be sure, the plane maker's problems don't have the exact same origin. Boeing got most of the big picture right, developing the lightweight 787 Dreamliner when Airbus was still entangled in making the A380 superjumbo. But it outsourced too much of its operations and skimped on quality control to disastrous effect.
Bu hikaye Mint Bangalore dergisinin January 01, 2025 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Mint Bangalore dergisinin January 01, 2025 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars
Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects
DIAL drops plea over Hindon ops expansion
Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.
Auto sales rise 9% in 2024 despite headwinds: Fada
Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec
Razorpay Charts Return to India; Eyes Expansion, IPO
Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years
Bank profits set to moderate in FY26 as bad assets rise
Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier
Lloyds Metals shines on likely gains from acquisition, capex
Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.
Another tough year for FMCG?
Feeling blue
Your fancy, new ETF might be a little too fancy
Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good
Risks to economy escalating in 2025, cautions SBICAPS
Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report
Intas Pharma bags another overseas company
Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.